7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Epstein-Barr virus (EBV) is a ubiquitous gammaherpesvirus which asymptomatically infects the majority of the world population. Under immunocompromised conditions, EBV can trigger human cancers of epithelial and lymphoid origin.

          ABSTRACT

          Epstein-Barr virus (EBV) is a ubiquitous gammaherpesvirus which asymptomatically infects the majority of the world population. Under immunocompromised conditions, EBV can trigger human cancers of epithelial and lymphoid origin. The oncogenic potential of EBV is demonstrated by in vitro infection and transformation of quiescent B cells into lymphoblastoid cell lines (LCLs). These cell lines, along with primary infection using genetically engineered viral particles coupled with recent technological advancements, have elucidated the underlying mechanisms of EBV-induced B-cell lymphomagenesis.

          Related collections

          Most cited references100

          • Record: found
          • Abstract: found
          • Article: not found

          The NCI60 human tumour cell line anticancer drug screen.

          The US National Cancer Institute (NCI) 60 human tumour cell line anticancer drug screen (NCI60) was developed in the late 1980s as an in vitro drug-discovery tool intended to supplant the use of transplantable animal tumours in anticancer drug screening. This screening model was rapidly recognized as a rich source of information about the mechanisms of growth inhibition and tumour-cell kill. Recently, its role has changed to that of a service screen supporting the cancer research community. Here I review the development, use and productivity of the screen, highlighting several outcomes that have contributed to advances in cancer chemotherapy.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Endogenous MHC class II processing of a viral nuclear antigen after autophagy.

            CD4+ T cells classically recognize antigens that are endocytosed and processed in lysosomes for presentation on major histocompatibility complex (MHC) class II molecules. Here, endogenous Epstein-Barr virus nuclear antigen 1 (EBNA1) was found to gain access to this pathway by autophagy. On inhibition of lysosomal acidification, EBNA1, the dominant CD4+ T cell antigen of latent Epstein-Barr virus infection, slowly accumulated in cytosolic autophagosomes. In addition, inhibition of autophagy decreased recognition by EBNA1-specific CD4+ T cell clones. Thus, lysosomal processing after autophagy may contribute to MHC class II-restricted surveillance of long-lived endogenous antigens including nuclear proteins relevant to disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Epstein–Barr virus latent genes

              Latent Epstein–Barr virus (EBV) infection has a substantial role in causing many human disorders. The persistence of these viral genomes in all malignant cells, yet with the expression of limited latent genes, is consistent with the notion that EBV latent genes are important for malignant cell growth. While the EBV-encoded nuclear antigen-1 (EBNA-1) and latent membrane protein-2A (LMP-2A) are critical, the EBNA-leader proteins, EBNA-2, EBNA-3A, EBNA-3C and LMP-1, are individually essential for in vitro transformation of primary B cells to lymphoblastoid cell lines. EBV-encoded RNAs and EBNA-3Bs are dispensable. In this review, the roles of EBV latent genes are summarized.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                J Virol
                J. Virol
                jvi
                jvi
                JVI
                Journal of Virology
                American Society for Microbiology (1752 N St., N.W., Washington, DC )
                0022-538X
                1098-5514
                10 April 2019
                14 June 2019
                1 July 2019
                14 June 2019
                : 93
                : 13
                : e00238-19
                Affiliations
                [a ]Department of Life Sciences, Presidency University, Kolkata, West Bengal, India
                [b ]Department of Otorhinolaryngology-Head and Neck Surgery, and the Tumor Virology Program, Abramson Comprehensive Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
                University of Arizona
                Author notes
                Address correspondence to Abhik Saha, abhik.dbs@ 123456presiuniv.ac.in , or Erle S. Robertson, erle@ 123456upenn.edu .

                Citation Saha A, Robertson ES. 2019. Mechanisms of B-cell oncogenesis induced by Epstein-Barr virus. J Virol 93:e00238-19. https://doi.org/10.1128/JVI.00238-19.

                Article
                00238-19
                10.1128/JVI.00238-19
                6580952
                30971472
                a6e50a35-b4ec-41f8-b2e5-3c1fb3b2148c
                Copyright © 2019 Saha and Robertson.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

                History
                : 11 February 2019
                : 8 April 2019
                Page count
                Figures: 2, Tables: 2, Equations: 0, References: 113, Pages: 13, Words: 8992
                Funding
                Funded by: Wellcome Trust/DBT India Alliance;
                Award ID: IA/I/14/2/501537
                Award Recipient :
                Funded by: HHS | National Institutes of Health (NIH), https://doi.org/10.13039/100000002;
                Award ID: P01CA174439
                Award ID: R01177423
                Award ID: R01171979
                Award ID: P30DK050306
                Award ID: P30CA016520
                Award ID: U54CA190158
                Award Recipient :
                Categories
                Gem
                Custom metadata
                July 2019

                Microbiology & Virology
                b-cell lymphomas,epstein-barr virus,lymphoblastoid cell lines,tumor virology

                Comments

                Comment on this article